1-Minute Healthcare News Today—May 23, 2023
The FDA authorized Opiant Pharmaceuticals Inc's nasal spray for reversing opioid-related overdoses on Monday, increasing treatment choices in the country's fight against a crisis that has killed hundreds of thousands. Read here.?
A new study from the University of California, Los Angeles, discovered some good news for cannabis smokers: one of the biggest dangers associated with tobacco smoking, Chronic Obstructive Pulmonary Disease, is not linked to marijuana. Learn more here.
Meanwhile,? Scientists have made a significant breakthrough by identifying brain signals that indicate the level of pain experienced by an individual. This discovery can potentially revolutionize the treatment options available for individuals suffering from severe and long-lasting chronic pain. Continue reading here.
A clinical trial has started for an influenza vaccine that utilizes messenger RNA (mRNA). Should this demonstrate its efficacy, it holds the potential to provide the general population with durable immunity against the virus over an extended period. Read here.
Lastly, Health authorities in Maine are cautioning residents about the potential threat of ticks following the unfortunate death of a Portland resident on May 17. The individual died due to a rare tick-borne Powassan virus, making it the state’s first recorded case of this untreatable ailment this year. Read here.